Short answer: both are type A botulinum toxins and do the same basic job; the choice usually comes down to the area treated and to how you personally have responded before. Where a wide area needs an even softening — a broad forehead, for instance — Dysport may be preferred, because it spreads somewhat further from the injection point. Where a small, sharply bounded area needs millimetre control — the glabella, around the eyes, a gummy smile — Botox is generally preferred. And if one product has worked well for you before, continuing with it is usually the most sensible option.
Technically, BOTOX (Allergan) contains onabotulinumtoxinA and Dysport (Ipsen) contains abobotulinumtoxinA. This is where the most common misunderstanding arises: the unit systems of the two products are not equivalent. "20 units of Botox" does not mean the same as "20 units of Dysport". The conversion is something the doctor calculates, and comparing unit counts between products as a patient is misleading. A product requiring more units is neither stronger nor weaker for it.
Onset and duration are also asked about constantly. With both products the effect begins within days of treatment and typically lasts a few months. Dysport is frequently reported to begin working slightly sooner, but this varies between individuals, and claiming a clear duration advantage for either product that a patient would actually notice would not be accurate. Longevity depends on muscle strength, the dose used, metabolism and how often treatment is repeated.
The treatment areas are shared: forehead lines, frown lines, crow's feet, and for non-cosmetic indications masseter or excessive sweating treatment. What really determines the plan is which muscle is strong and how strong, your brow position and your eyelid anatomy. The same dose produces very different results on two different faces, which is why "my friend had this many units" is not a useful measure.
Limits: botulinum toxin works on dynamic lines caused by muscle movement. It does not on its own erase static lines that remain etched in the skin when the face is at rest; those call for filler, collagen stimulation or skin resurfacing. It does not tighten sagging skin, does not replace lost volume and does not change skin quality. It is not used during pregnancy or breastfeeding, in neuromuscular junction disorders such as myasthenia gravis, where there is active infection at the injection site, or in known hypersensitivity. You should disclose your medications, particularly aminoglycoside antibiotics and muscle relaxants. Very frequent treatment at unnecessarily high doses can reduce the response over time.
Results vary from person to person with muscle structure, age and tissue response; no particular duration or outcome can be guaranteed. Which product is used, in which area and at what dose can only be determined by a medical consultation.